Alps Advisors Inc Savara Inc Transaction History

Alps Advisors Inc

$14.1 Billion
Q1 2024

A detailed history of Alps Advisors Inc transactions in Savara Inc stock. As of the latest transaction made, Alps Advisors Inc holds 95,462 shares of SVRA stock, worth $413,350. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,462

Previous 90,919 5.0%

Holding current value

$413,350

Previous $427,000 11.24%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.19 - $5.59 $19,035 - $25,395	4,543 Added 5.0%	95,462 $475,000
Q4 2023 Feb 14, 2024	BUY	$3.18 - $4.9 $289,122 - $445,503	90,919 New	90,919 $427,000
Q4 2021 Feb 09, 2022	SELL	$1.04 - $1.34 $149,136 - $192,156	-143,400 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.18 - $1.64 $7,415 - $10,305	-6,284 Reduced 4.2%	143,400 $198,000
Q2 2021 Aug 11, 2021	BUY	$1.51 - $2.29 $226,022 - $342,776	149,684 New	149,684 $254,000

Q4 2019 Feb 07, 2020	SELL	$0.71 - $4.91 $58,337 - $403,435	-82,166 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$2.16 - $3.2 $15,487 - $22,944	7,170 Added 9.56%	82,166 $218,000
Q2 2019 Aug 07, 2019	SELL	$2.37 - $11.7 $23,353 - $115,291	-9,854 Reduced 11.61%	74,996 $178,000
Q1 2019 May 01, 2019	BUY	$6.71 - $8.6 $24,625 - $31,562	3,670 Added 4.52%	84,850 $625,000
Q4 2018 Feb 04, 2019	BUY	$6.27 - $10.92 $119,612 - $208,320	19,077 Added 30.72%	81,180 $615,000
Q3 2018 Oct 25, 2018	BUY	$10.49 - $12.87 $185,547 - $227,644	17,688 Added 39.82%	62,103 $693,000
Q2 2018 Aug 02, 2018	BUY	$8.55 - $13.76 $90,775 - $146,089	10,617 Added 31.41%	44,415 $503,000
Q2 2018 Jul 25, 2018	SELL	$8.55 - $13.76 $60,781 - $97,819	-7,109 Reduced 17.38%	33,798 $502,000
Q1 2018 May 01, 2018	BUY	$8.99 - $14.95 $63,909 - $106,279	7,109 Added 21.03%	40,907 $376,000
Q4 2017 Feb 05, 2018	BUY	$8.26 - $16.76 $279,171 - $566,454	33,798	33,798 $502,000

Others Institutions Holding SVRA

# of Institutions

122

Shares Held

121M

Call Options Held

123K

Put Options Held

14.7K

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $494M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Savara Inc Transaction History